Make It So
The extended release oral dosage form developed by Gio Traverso and colleagues has the potential to vastly improve drug delivery and compliance; but how easy will it be to bring to market?
Lyndra, Inc. (Watertown, MA, USA) was formed to commercialise the gastro-resident system; here we catch up with Ray Knox (Senior Vice-President of Manufacturing) and Ellie McGuire (Head of Business Development) to hear about the company's recent progress.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.